Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frederick L Locke

Showing results (1-10 of 234) with videos related to

Pageof 24
Sort By:
Clinical Advances in Hematology & Oncology : H&O|July 29, 2020
Highlights in CAR T-Cell Therapy in Lymphoma From the 60th American Society of Hematology Annual Meeting: CommentaryFrederick L Locke
Clinical Advances in Hematology & Oncology : H&O|August 25, 2017
Highlights in Aggressive Non-Hodgkin Lymphoma From the 2017 American Society of Clinical Oncology Annual Meeting: CommentaryFrederick L Locke
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 20, 2020
Chimeric Antigen Receptor T Cell Therapy Delivers Response in Lymphoma Progressing after Allogeneic Transplantation, but is the Sequence Optimal?Frederick L Locke
Journal for Immunotherapy of Cancer|July 19, 2017
Transplanters drive CARs to the clinic by brewing ICE-T: the Moffitt roadmapFrederick L Locke, Claudio Anasetti,
Blood|December 27, 2019
Beat pediatric ALL MRD: CD28 CAR T and transplantMarco Ruella, Frederick L Locke
Clinical Advances in Hematology & Oncology : H&O|May 10, 2018
Advances in aggressive lymphoma from the 2017 American Society of Hematology Annual Meeting and Exposition: commentaryFrederick L Locke, Faysal Haroun
Blood|January 6, 2018
Off-the-shelf TCR for graft-versus-leukemia without GVHDFrederick L Locke, Claudio Anasetti
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 21, 2021
Seeing the Light: CAR T-cell Targeting of Lambda-restricted B-cell LymphomasMichael D Jain, Frederick L Locke
Clinical Advances in Hematology & Oncology : H&O|October 10, 2018
Advances in aggressive lymphoma from the 2018 American Society of Clinical Oncology annual meeting: commentaryFrederick L Locke, Michael D Jain
Hematology/Oncology Clinics of North America|August 14, 2023
Mechanisms of Resistance to Chimeric Antigen Receptor T Cell TherapyGrace A Johnson, Frederick L Locke
Pageof 24

Showing results (1-10 of 234) with videos related to

Sort By:
Pageof 24
Clinical Advances in Hematology & Oncology : H&O|July 29, 2020
Highlights in CAR T-Cell Therapy in Lymphoma From the 60th American Society of Hematology Annual Meeting: CommentaryFrederick L Locke
Clinical Advances in Hematology & Oncology : H&O|August 25, 2017
Highlights in Aggressive Non-Hodgkin Lymphoma From the 2017 American Society of Clinical Oncology Annual Meeting: CommentaryFrederick L Locke
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 20, 2020
Chimeric Antigen Receptor T Cell Therapy Delivers Response in Lymphoma Progressing after Allogeneic Transplantation, but is the Sequence Optimal?Frederick L Locke
Journal for Immunotherapy of Cancer|July 19, 2017
Transplanters drive CARs to the clinic by brewing ICE-T: the Moffitt roadmapFrederick L Locke, Claudio Anasetti,
Blood|December 27, 2019
Beat pediatric ALL MRD: CD28 CAR T and transplantMarco Ruella, Frederick L Locke
Clinical Advances in Hematology & Oncology : H&O|May 10, 2018
Advances in aggressive lymphoma from the 2017 American Society of Hematology Annual Meeting and Exposition: commentaryFrederick L Locke, Faysal Haroun
Blood|January 6, 2018
Off-the-shelf TCR for graft-versus-leukemia without GVHDFrederick L Locke, Claudio Anasetti
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 21, 2021
Seeing the Light: CAR T-cell Targeting of Lambda-restricted B-cell LymphomasMichael D Jain, Frederick L Locke
Clinical Advances in Hematology & Oncology : H&O|October 10, 2018
Advances in aggressive lymphoma from the 2018 American Society of Clinical Oncology annual meeting: commentaryFrederick L Locke, Michael D Jain
Hematology/Oncology Clinics of North America|August 14, 2023
Mechanisms of Resistance to Chimeric Antigen Receptor T Cell TherapyGrace A Johnson, Frederick L Locke
Pageof 24